JP2011509156A5 - - Google Patents

Download PDF

Info

Publication number
JP2011509156A5
JP2011509156A5 JP2010542335A JP2010542335A JP2011509156A5 JP 2011509156 A5 JP2011509156 A5 JP 2011509156A5 JP 2010542335 A JP2010542335 A JP 2010542335A JP 2010542335 A JP2010542335 A JP 2010542335A JP 2011509156 A5 JP2011509156 A5 JP 2011509156A5
Authority
JP
Japan
Prior art keywords
polymer
conduit
poly
item
vascular graft
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010542335A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011509156A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/030407 external-priority patent/WO2009089324A1/en
Publication of JP2011509156A publication Critical patent/JP2011509156A/ja
Publication of JP2011509156A5 publication Critical patent/JP2011509156A5/ja
Pending legal-status Critical Current

Links

JP2010542335A 2008-01-08 2009-01-08 血管移植片の開存性を促進するための組成物および方法 Pending JP2011509156A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1040608P 2008-01-08 2008-01-08
PCT/US2009/030407 WO2009089324A1 (en) 2008-01-08 2009-01-08 Compositions and methods for promoting patency of vascular grafts

Publications (2)

Publication Number Publication Date
JP2011509156A JP2011509156A (ja) 2011-03-24
JP2011509156A5 true JP2011509156A5 (cg-RX-API-DMAC10.html) 2013-02-21

Family

ID=40352092

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010542335A Pending JP2011509156A (ja) 2008-01-08 2009-01-08 血管移植片の開存性を促進するための組成物および方法

Country Status (3)

Country Link
US (3) US9855370B2 (cg-RX-API-DMAC10.html)
JP (1) JP2011509156A (cg-RX-API-DMAC10.html)
WO (1) WO2009089324A1 (cg-RX-API-DMAC10.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9855370B2 (en) 2008-01-08 2018-01-02 Yale University Compositions and methods for promoting patency of vascular grafts
WO2013003157A1 (en) * 2011-06-28 2013-01-03 Yale University Cell-free tissued engineered vascular grafts
US10195252B2 (en) 2012-08-03 2019-02-05 University of Pittsburgh—of the Commonwealth System of Higher Education Recruitment of mensenchymal cells using controlled release systems
WO2015148775A1 (en) * 2014-03-27 2015-10-01 Board Of Regents, The University Of Texas System Compositions and methods for growing autologous biological tissue
WO2017100782A1 (en) * 2015-12-11 2017-06-15 Research Institute At Nationwide Children's Hospital Systems and methods for optimized patent specific tissue engineering vascular grafts
US20200054790A1 (en) * 2017-05-02 2020-02-20 The Johns Hopkins University Implantable vascular grafts
WO2021097419A1 (en) * 2019-11-15 2021-05-20 Research Institute At Nationwide Children's Hospital Systems and methods producing seeded grafts
CN119454907A (zh) * 2025-01-09 2025-02-18 浙江大学 Vegf-c156s在制备减轻静脉移植物狭窄的药物中的应用

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459128A (en) * 1993-11-12 1995-10-17 Dana-Farber Cancer Institute Human monocyte chemoattractant protein-1 (MCP-1) derivatives
US5716394A (en) 1994-04-29 1998-02-10 W. L. Gore & Associates, Inc. Blood contact surfaces using extracellular matrix synthesized in vitro
US6774278B1 (en) 1995-06-07 2004-08-10 Cook Incorporated Coated implantable medical device
US5922554A (en) 1995-10-30 1999-07-13 The Regents Of The University Of California Inhibition of cellular uptake of cholesterol
EP0880586A1 (en) 1996-02-01 1998-12-02 The University Of Florida Lyst1 and lyst2 gene compositions and methods of use
GB9716657D0 (en) * 1997-08-07 1997-10-15 Zeneca Ltd Chemical compounds
AU3214099A (en) 1998-04-03 1999-10-25 Curagen Corporation Lyst protein complexes and lyst interacting proteins
US6984400B2 (en) 1998-07-14 2006-01-10 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method of treating restenosis using bisphosphonate nanoparticles
US7008645B2 (en) 1998-07-14 2006-03-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method of inhibiting restenosis using bisphosphonates
US6184226B1 (en) 1998-08-28 2001-02-06 Scios Inc. Quinazoline derivatives as inhibitors of P-38 α
FR2785812B1 (fr) * 1998-11-16 2002-11-29 Commissariat Energie Atomique Protheses bioactives, notamment a proprietes immunosuppressives, antistenose et antithrombose, et leur fabrication
US7763580B2 (en) 1999-01-05 2010-07-27 University Of Utah Research Foundation Methods for treating conditions associated with the accumulation of excess extracellular matrix
GB9902455D0 (en) * 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
AU4798000A (en) 1999-04-09 2000-11-14 Smithkline Beecham Corporation Triarylimidazoles
CA2379909C (en) 1999-08-06 2011-01-04 Board Of Regents, The University Of Texas System Drug releasing biodegradable fiber implant
US20020125613A1 (en) 2001-03-08 2002-09-12 Cominsky Kenneth D. Mandrel fabrication for cobond assembly
US6660034B1 (en) * 2001-04-30 2003-12-09 Advanced Cardiovascular Systems, Inc. Stent for increasing blood flow to ischemic tissues and a method of using the same
CA2449978A1 (en) * 2001-06-15 2002-12-27 Johns Hopkins Singapore Pte Ltd Biofunctional fibers
US20030064965A1 (en) 2001-10-02 2003-04-03 Jacob Richter Method of delivering drugs to a tissue using drug-coated medical devices
KR20040051618A (ko) 2001-10-25 2004-06-18 위스콘신 얼럼나이 리서어치 화운데이션 단백질 티로신 키나아제 저해제로 피복되거나 함침된 혈관스텐트 또는 이식물 및 그를 사용하는 방법
WO2003037400A2 (en) * 2001-10-31 2003-05-08 Ventrigraft Inc Methods and device compositions for the recruitment of cells to blood contacting surfaces in vivo
US20040063654A1 (en) 2001-11-02 2004-04-01 Davis Mark E. Methods and compositions for therapeutic use of RNA interference
GB0217786D0 (en) 2002-07-31 2002-09-11 Glaxo Group Ltd Compounds
US20050163821A1 (en) * 2002-08-02 2005-07-28 Hsing-Wen Sung Drug-eluting Biodegradable Stent and Delivery Means
EP1542724A4 (en) * 2002-08-19 2005-10-19 Abgenix Inc ANTIBODIES AGAINST THE MONOCYTE 1 CHIMIOATTRACTIVE PROTEIN (MCP-1) AND USES THEREOF
US7405299B2 (en) 2002-11-27 2008-07-29 Eli Lilly And Company Compounds as pharmaceutical agents
WO2004073504A2 (en) * 2003-02-20 2004-09-02 Proteon Therapeutics, Llc Methods for the treatment and prevention of diseases of biological conduits
DE602004015429D1 (de) 2003-03-11 2008-09-11 Pfizer Prod Inc Pyrazinverbindungen als inhibitoren des transforming growth factor (tgf)
ES2389258T3 (es) 2003-06-17 2012-10-24 Millennium Pharmaceuticals, Inc. Composiciones y métodos para inhibir TGF-s
US20080206219A1 (en) 2003-08-08 2008-08-28 The Regencts Of The University Of California Novel Indications for Transforming Growth Factor-Beta Regulators
AU2004277302B2 (en) 2003-09-29 2010-08-26 Hemoteq Ag Biocompatible, biostable coating of medical surfaces
CA2536042A1 (en) * 2003-11-10 2005-06-02 Angiotech International Ag Medical implants and anti-scarring agents
US6997989B2 (en) * 2003-12-08 2006-02-14 Boston Scientific Scimed, Inc. Medical implant processing chamber
ES2346226T3 (es) 2003-12-30 2010-10-13 Augustinus Bader Uso de la eritropoyetina para la regeneracion de tejido hepatico.
DE602005020754D1 (de) 2004-03-31 2010-06-02 Cook Inc Transplantatmaterial und gefässprothese mit extrazellulärer kollagenmatrix und dessen herstellungsverfahren
US7763065B2 (en) 2004-07-21 2010-07-27 Reva Medical, Inc. Balloon expandable crush-recoverable stent device
JP5144000B2 (ja) 2004-08-25 2013-02-13 太陽化学株式会社 形質転換増殖因子β抑制用組成物
JP2008511631A (ja) 2004-08-31 2008-04-17 バイオジェン・アイデック・エムエイ・インコーポレイテッド ＴＧＦ−βインヒビターとしてのピリミジニルイミダゾール
WO2006099332A2 (en) 2005-03-11 2006-09-21 Wake Forest University Health Sciences Production of tissue engineered digits and limbs
US20060217437A1 (en) 2005-03-17 2006-09-28 Burmester James K TGF-beta modulators and methods for using the same
SG192440A1 (en) * 2005-11-15 2013-08-30 Orbusneich Medical Inc Progenitor endothelial cell capturing with a drug eluting implantable medical device
CN101553244B (zh) 2006-07-21 2013-01-02 普罗米克斯有限公司 内膜增生和相关病状的治疗
WO2008039521A2 (en) * 2006-09-26 2008-04-03 Nmt Medical, Inc. Method for modifying a medical implant surface for promoting tissue growth
EP2527345B1 (en) 2006-10-16 2015-12-16 Thesan Pharmaceuticals, Inc. Therapeutic pyrazolyl thienopyridines
US7959942B2 (en) 2006-10-20 2011-06-14 Orbusneich Medical, Inc. Bioabsorbable medical device with coating
US20100076544A1 (en) 2007-01-30 2010-03-25 Erika Hoffmann Biodegradable vascular support
KR100932688B1 (ko) 2007-07-06 2009-12-21 한국과학기술연구원 인공혈관용 이중막 구조의 튜브형 다공성 스캐폴드 및 그의제조방법
US20090043378A1 (en) * 2007-08-10 2009-02-12 Medtronic Vascular, Inc. Biocompatible Polymer System for Extended Drug Release
US8277832B2 (en) 2007-10-10 2012-10-02 The University Of Kansas Microsphere-based materials with predefined 3D spatial and temporal control of biomaterials, porosity and/or bioactive signals
US7824601B1 (en) 2007-11-14 2010-11-02 Abbott Cardiovascular Systems Inc. Process of making a tubular implantable medical device
US9855370B2 (en) 2008-01-08 2018-01-02 Yale University Compositions and methods for promoting patency of vascular grafts
US20100092534A1 (en) * 2008-10-10 2010-04-15 Medtronic Vascular, Inc. Combination Local Delivery Using a Stent
US20100129414A1 (en) 2008-11-24 2010-05-27 Medtronic Vascular, Inc. Bioactive Agent Delivery Using Liposomes in Conjunction With Stent Deployment
RU2440128C1 (ru) 2010-05-17 2012-01-20 Государственное образовательное учреждение дополнительного профессионального образования "Санкт-Петербургская медицинская академия последипломного образования Федерального агентства по здравоохранению и социальному развитию" (ГОУ ДПО СПбМАПО Росздрава) Способ комплексной патогенетической терапии острых форм вирусного гепатита в и микст-гепатитов (в+с, в+d, в+с+d)
CN102884172B (zh) 2010-05-17 2016-01-20 耶鲁大学 用于将细胞种植到三维支架上的系统
US9090863B2 (en) 2010-05-17 2015-07-28 Pall Corporation System for seeding cells onto three dimensional scaffolds
US20130013083A1 (en) 2011-01-06 2013-01-10 Humacyte Tissue-Engineered Constructs
US10227568B2 (en) 2011-03-22 2019-03-12 Nanofiber Solutions, Llc Fiber scaffolds for use in esophageal prostheses
WO2013003157A1 (en) 2011-06-28 2013-01-03 Yale University Cell-free tissued engineered vascular grafts
CN105209678A (zh) 2013-03-15 2015-12-30 纳米纤维解决方案股份有限公司 用于植入的生物相容的纤维织物
WO2014197790A1 (en) 2013-06-06 2014-12-11 University Of Maryland, College Park Compositions and methods for making biodegradable structures
WO2017100782A1 (en) 2015-12-11 2017-06-15 Research Institute At Nationwide Children's Hospital Systems and methods for optimized patent specific tissue engineering vascular grafts

Similar Documents

Publication Publication Date Title
JP5456272B2 (ja) 抗血栓剤複合体を含有する医療用具用コーティング
JP5442223B2 (ja) 抗血栓性抱合体を使用したコーティング
JP2016005809A5 (cg-RX-API-DMAC10.html)
US20210128795A1 (en) Spiral coated stent with controllable gradient degradation, preparation method thereof and application thereof
JP2008505705A5 (cg-RX-API-DMAC10.html)
DE102008021894A1 (de) Implantat umfassend eine Oberfläche mit verringerter Thrombogenität
JP2009542418A (ja) 埋込み型医療デバイスのための相分離したブロックコポリマーコーティング
WO2010127584A1 (zh) 一种凹槽携载式涂层可降解型药物洗脱支架
JP2014528798A (ja) ゴム補強された生体吸収性ポリマー末梢足場
Kwon et al. Biodegradable stent
JP2012533407A5 (cg-RX-API-DMAC10.html)
US20140010858A1 (en) Polymers For Implantable Devices Exhibiting Shape-Memory Effects
JP2005510521A5 (cg-RX-API-DMAC10.html)
CN101147813A (zh) 一种药物涂层载体及药物涂层血管支架的制备方法
JP2008289853A (ja) 抗血栓共役体を有する医療装置用のコーティング剤
CA2640750A1 (en) Polymeric, degradable drug-eluting stents and coatings comprising copolymers or homopolymers of 4-hydroxybutyrate
CN110520166A (zh) 抑制血小板吸收
US20200108182A1 (en) Self-expandable stent and method of producing the same
JP2011506641A (ja) 吸収性ポリマー複合材料における界面を改善するためのカップリング剤の使用
JP2011019918A (ja) 抗血栓性複合体を有する医療装置用コーティング
CN201404319Y (zh) 药物缓释支架
US12042579B2 (en) Self-expanding stent and manufacturing method therefor
DE102010034783A1 (de) Verfahren zur Herstellung von Hydroxypropylcellulose-Formteilen sowie deren Verwendung
EP2419155B1 (de) Beschichteter stent
EP3452128B1 (en) Modified biodegradable and medical polymer devices and a method for preparing the same